4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-042815
Chief Science & Business Off acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Poradosu Enrique · Chief Science & Business Off
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-01 | Grant or award : show line 1 in the form | +60,000 | 1,257,649 | D |
Loading xslF345X03/tm2211420-3_4seq1.xml…